PRECEDE BIO INSIGHT
LIVE

Serial Number

99603645

Owner

Precede Biosciences, Inc.

Attorney

Caitlin R. Byczko

Filing Date

Jan 20, 2026

Add to watchlist:

No watchlists yet
View on USPTO

PRECEDE BIO INSIGHT Trademark

Serial Number: 99603645

PRECEDE BIO INSIGHT is a trademark filed by Precede Biosciences, Inc. on January 20, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Precede Biosciences, Inc.

1 Design Center Place, 5th Floor
Boston, MA 02210

Entity Type: 03

Trademark Details

Filing Date

January 20, 2026

Registration Date

Not Registered

Goods & Services

medical testing and diagnostic services; clinical pathology services, namely, medical pathology services; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons in the nature of genomic and epigenomic profiling of human biological samples; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services; diagnostics services, namely, the recommendation of medical treatment for identified disease states

Software as a service (SAAS) services featuring software for inputting, accessing, viewing, processing and analyzing medical data; data as a service (DAAS) services featuring non-downloadable software for the provision of data, namely, for inputting, accessing, viewing, processing and analyzing medical data; computer services, namely, providing data as a service (DaaS) services featuring non-downloadable software for analyzing and managing data for purposes of drug development and discovery; computer services, namely, the provision of data as a service (DaaS) in the pharmaceuticals and healthcare fields for analyzing medical research data information in relation to pharmaceutical drug discovery and drug development; pharmaceutical research and development; pharmaceutical drug development and drug discovery services; medical research and scientific research; providing medical and scientific research information in the field of pharmaceuticals research and development of technology in the field of pharmaceuticals; biomedical research services; product development in the field of pharmaceuticals, namely, the development of preclinical and therapeutic product

diagnostic assays and reagents for clinical and medical use, namely, for the testing of body fluids; diagnostic chemical, biochemical and biological preparations for medical purposes, namely, for treating and preventing cancers and other clinical pathologies; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 26, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 26, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 26, 2026 CNRT
ASSIGNED TO EXAMINER
May 17, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 7, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 20, 2026 MAFR
NEW APPLICATION ENTERED
Jan 20, 2026 NWAP